News

Actions

Nuventra Renovates & Expands Durham Headquarters to Accommodate Growth

Posted at 8:01 AM, Feb 19, 2019
and last updated 2019-02-19 08:01:31-05

DURHAM, N.C.--(BUSINESS WIRE)--Feb 19, 2019--Nuventra Pharma Sciences ( www.nuventra.com ) is excited to announce the completion of its newly renovated company headquarters in Durham, NC.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190219005250/en/

Nuventra's New Office Space in Durham, NC (Photo: Business Wire)

The expanded and redesigned 15,000 square foot space features eight conference rooms and three breakrooms. New floors, paint, and lighting features give the location a modern and bright feel. The space is equipped with adjustable desks to give employees the flexibility to sit or stand throughout the day, as well as two treadmill desks available for intervallic use.

Nuventra has experienced steady growth over the past several years, and this expansion provides the office space required to support that growth. The company has brought on twelve new employees since the start of 2019, with substantial hiring plans for the remainder of the year.

“We are excited to open our new headquarters in Durham, ” said Geoffrey Banks, Ph.D., Nuventra’s CEO. “We designed the space to be open and collaborative for our employees and to support our growth strategy.”

Two other Nuventra locations are also expanding to accommodate growth. Nuventra’s second largest office in Exton, PA recently completed an office expansion and renovation. The Broomfield, CO office will move to a larger space that is expected to be completed in March.

Nuventra’s current job openings can be found at www.nuventra.com/jobs.

About Nuventra

Nuventra is the pharmaceutical industry’s go-to resource for clinical pharmacology, pharmacokinetic, and pharmacometric consulting services. Nuventra gives pharmaceutical companies and CROs rare access to a hands-on team of industry-leading consultants experienced in complex studies and analyses. We embrace the notion that simplicity and clarity lead to good decisions by taking complex pharmacokinetic and pharmacometric principals and making them understandable and usable for common sense drug development. Read more at www.nuventra.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190219005250/en/

CONTACT: Kelly Gelinne

Senior Marketing Manager

kgelinne@nuventra.com

919.740.5137

KEYWORD: UNITED STATES NORTH AMERICA NORTH CAROLINA

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL OTHER HEALTH RESEARCH OTHER SCIENCE SCIENCE

SOURCE: Nuventra

Copyright Business Wire 2019.

PUB: 02/19/2019 08:00 AM/DISC: 02/19/2019 08:01 AM

http://www.businesswire.com/news/home/20190219005250/en